176 related articles for article (PubMed ID: 37335049)
1. NAD
Yaku K; Nakagawa T
Antioxid Redox Signal; 2023 Dec; 39(16-18):1133-1149. PubMed ID: 37335049
[No Abstract] [Full Text] [Related]
2. NAD+ Precursors Nicotinamide Mononucleotide (NMN) and Nicotinamide Riboside (NR): Potential Dietary Contribution to Health.
Alegre GFS; Pastore GM
Curr Nutr Rep; 2023 Sep; 12(3):445-464. PubMed ID: 37273100
[TBL] [Abstract][Full Text] [Related]
3. Role of Nicotinamide Adenine Dinucleotide and Related Precursors as Therapeutic Targets for Age-Related Degenerative Diseases: Rationale, Biochemistry, Pharmacokinetics, and Outcomes.
Braidy N; Berg J; Clement J; Khorshidi F; Poljak A; Jayasena T; Grant R; Sachdev P
Antioxid Redox Signal; 2019 Jan; 30(2):251-294. PubMed ID: 29634344
[No Abstract] [Full Text] [Related]
4. The therapeutic perspective of NAD
Iqbal T; Nakagawa T
Biochem Biophys Res Commun; 2024 Apr; 702():149590. PubMed ID: 38340651
[TBL] [Abstract][Full Text] [Related]
5. A Narrative Review of Nicotinamide Adenine Dinucleotide (NAD)+ Intermediates Nicotinamide Riboside and Nicotinamide Mononucleotide for Keratinocyte Carcinoma Risk Reduction.
Kahn B; Borrelli M; Libby T
J Drugs Dermatol; 2022 Oct; 21(10):1129-1132. PubMed ID: 36219044
[TBL] [Abstract][Full Text] [Related]
6. MIB-626, an Oral Formulation of a Microcrystalline Unique Polymorph of β-Nicotinamide Mononucleotide, Increases Circulating Nicotinamide Adenine Dinucleotide and its Metabolome in Middle-Aged and Older Adults.
Pencina KM; Lavu S; Dos Santos M; Beleva YM; Cheng M; Livingston D; Bhasin S
J Gerontol A Biol Sci Med Sci; 2023 Jan; 78(1):90-96. PubMed ID: 35182418
[TBL] [Abstract][Full Text] [Related]
7. Nicotinamide riboside kinases display redundancy in mediating nicotinamide mononucleotide and nicotinamide riboside metabolism in skeletal muscle cells.
Fletcher RS; Ratajczak J; Doig CL; Oakey LA; Callingham R; Da Silva Xavier G; Garten A; Elhassan YS; Redpath P; Migaud ME; Philp A; Brenner C; Canto C; Lavery GG
Mol Metab; 2017 Aug; 6(8):819-832. PubMed ID: 28752046
[TBL] [Abstract][Full Text] [Related]
8. NAD
Yoshino J; Baur JA; Imai SI
Cell Metab; 2018 Mar; 27(3):513-528. PubMed ID: 29249689
[TBL] [Abstract][Full Text] [Related]
9. Reversal of endothelial dysfunction by nicotinamide mononucleotide via extracellular conversion to nicotinamide riboside.
Mateuszuk Ł; Campagna R; Kutryb-Zając B; Kuś K; Słominska EM; Smolenski RT; Chlopicki S
Biochem Pharmacol; 2020 Aug; 178():114019. PubMed ID: 32389638
[TBL] [Abstract][Full Text] [Related]
10. Safety and efficacy of long-term nicotinamide mononucleotide supplementation on metabolism, sleep, and nicotinamide adenine dinucleotide biosynthesis in healthy, middle-aged Japanese men.
Yamaguchi S; Irie J; Mitsuishi M; Uchino Y; Nakaya H; Takemura R; Inagaki E; Kosugi S; Okano H; Yasui M; Tsubota K; Hayashi K; Yoshino J; Itoh H
Endocr J; 2024 Feb; 71(2):153-169. PubMed ID: 38191197
[TBL] [Abstract][Full Text] [Related]
11. Hydroxyapatite-based nano-drug delivery system for nicotinamide mononucleotide (NMN): significantly enhancing NMN bioavailability and replenishing in vivo nicotinamide adenine dinucleotide (NAD+) levels.
Zhang D; Yau LF; Bai LB; Tong TT; Cao KY; Yan TM; Zeng L; Jiang ZH
J Pharm Pharmacol; 2023 Dec; 75(12):1569-1580. PubMed ID: 37862582
[TBL] [Abstract][Full Text] [Related]
12. Oral Administration of Nicotinamide Mononucleotide Increases Nicotinamide Adenine Dinucleotide Level in an Animal Brain.
Ramanathan C; Lackie T; Williams DH; Simone PS; Zhang Y; Bloomer RJ
Nutrients; 2022 Jan; 14(2):. PubMed ID: 35057482
[TBL] [Abstract][Full Text] [Related]
13. Precursor comparisons for the upregulation of nicotinamide adenine dinucleotide. Novel approaches for better aging.
Palmer RD; Elnashar MM; Vaccarezza M
Aging Med (Milton); 2021 Sep; 4(3):214-220. PubMed ID: 34553119
[TBL] [Abstract][Full Text] [Related]
14. Oral Administration of Nicotinamide Mononucleotide Is Safe and Efficiently Increases Blood Nicotinamide Adenine Dinucleotide Levels in Healthy Subjects.
Okabe K; Yaku K; Uchida Y; Fukamizu Y; Sato T; Sakurai T; Tobe K; Nakagawa T
Front Nutr; 2022; 9():868640. PubMed ID: 35479740
[TBL] [Abstract][Full Text] [Related]
15. NRK1 controls nicotinamide mononucleotide and nicotinamide riboside metabolism in mammalian cells.
Ratajczak J; Joffraud M; Trammell SA; Ras R; Canela N; Boutant M; Kulkarni SS; Rodrigues M; Redpath P; Migaud ME; Auwerx J; Yanes O; Brenner C; Cantó C
Nat Commun; 2016 Oct; 7():13103. PubMed ID: 27725675
[TBL] [Abstract][Full Text] [Related]
16. The Safety and Antiaging Effects of Nicotinamide Mononucleotide in Human Clinical Trials: an Update.
Song Q; Zhou X; Xu K; Liu S; Zhu X; Yang J
Adv Nutr; 2023 Nov; 14(6):1416-1435. PubMed ID: 37619764
[TBL] [Abstract][Full Text] [Related]
17. Dietary Supplementation With NAD+-Boosting Compounds in Humans: Current Knowledge and Future Directions.
Freeberg KA; Udovich CC; Martens CR; Seals DR; Craighead DH
J Gerontol A Biol Sci Med Sci; 2023 Dec; 78(12):2435-2448. PubMed ID: 37068054
[TBL] [Abstract][Full Text] [Related]
18. Implications of altered NAD metabolism in metabolic disorders.
Okabe K; Yaku K; Tobe K; Nakagawa T
J Biomed Sci; 2019 May; 26(1):34. PubMed ID: 31078136
[TBL] [Abstract][Full Text] [Related]
19. Function of NAD metabolism in white adipose tissue: lessons from mouse models.
Kwon SY; Park YJ
Adipocyte; 2024 Dec; 13(1):2313297. PubMed ID: 38316756
[TBL] [Abstract][Full Text] [Related]
20. NAD+ therapy in age-related degenerative disorders: A benefit/risk analysis.
Braidy N; Liu Y
Exp Gerontol; 2020 Apr; 132():110831. PubMed ID: 31917996
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
